GRCE GRACE THERAPEUTICS INC Capital Structure Changes 8-K Filing 2023 - Compliance Extension Acasti Pharma Inc. has received an extension until July 24, 2023, to regain compliance with the minimum bid price requirement for continued listing on Nasdaq.Get access to all SEC 8-K filings of the GRACE THERAPEUTICS INC